Will Patients With Liver Metastasis From Aggressives Cancers Benefit From Surgical Resection?

BACKGROUND: We aimed to evaluate the outcomes of resections for liver metastases (LMs) originating from pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), and esophagus/gastric cancers (EGCs), which we label as major killers (MKs; overall survival (OS) under 10%). We hypoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Farai, Abdallah, Garnier, Jonathan, Palen, Anais, Ewald, Jacques, Delpero, Jean-Robert, Turrini, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822689/
https://www.ncbi.nlm.nih.gov/pubmed/36660208
http://dx.doi.org/10.14740/wjon1516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822689/
https://www.ncbi.nlm.nih.gov/pubmed/36660208
http://dx.doi.org/10.14740/wjon1516

Ejemplares similares